NOVEL CARBOHYDRATE CONJUGATES AS POTENTIAL PRODRUGS OF ACYCLOVIR

被引:6
作者
CHAMBERLAIN, SD
MOORMAN, AR
BURNETTE, TC
DEMIRANDA, P
KRENITSKY, TA
机构
[1] Wellcome Research Laboratories, Research Triangle Park
关键词
D O I
10.1177/095632029400500202
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fifteen novel carbohydrate conjugates of desciclovir (2-[(2-amino-9H-purin-9-yl]-methoxy]ethanol) were synthesized and evaluated as potential double prodrugs for acyclovir. The compounds were prepared by an acid-catalyzed reaction between reducing sugars and the P-amino group of desciclovir. Spectral data indicated that the carbohydrate moieties in the products were predominately in the pyranose form. The suitability of each analogue as a double prodrug of acyclovir was evaluated by the urinary recovery of acyclovir from rats after oral dosing. The results showed that these highly water-soluble conjugates were poor prodrugs. Similar results were obtained with the glucose conjugate of acyclovir itself. A comparison of intraperitoneal vs. oral administration for six of the conjugates suggested that the unsuitability of these conjugates as prodrugs results from poor gastrointestinal absorption as well as inefficient metabolic removal of the carbohydrate moieties.
引用
收藏
页码:64 / 73
页数:10
相关论文
共 24 条
[1]   STRUCTURAL REQUIREMENTS FOR ACTIVE INTESTINAL TRANSPORT - NATURE OF CARRIER-SUGAR BONDING AT C-2 AND RING OXYGEN OF SUGAR [J].
BARNETT, JEG ;
RALPH, A ;
MUNDAY, KA .
BIOCHEMICAL JOURNAL, 1970, 118 (05) :843-&
[2]   AMINO-ACID ESTER PRODRUGS OF ACYCLOVIR [J].
BEAUCHAMP, LM ;
ORR, GF ;
DEMIRANDA, P ;
BURNETTE, T ;
KRENITSKY, TA .
ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1992, 3 (03) :157-164
[3]   INVITRO SUSCEPTIBILITY OF VARICELLA-ZOSTER VIRUS TO ACYCLOVIR [J].
BIRON, KK ;
ELION, GB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 18 (03) :443-447
[4]   STRUCTURE OF SOME N-ARYL-D-GLUCOSYLAMINES [J].
CAPON, B ;
CONNETT, BE .
JOURNAL OF THE CHEMICAL SOCIETY, 1965, (AUG) :4492-&
[5]   SYNTHESIS AND ANTIVIRAL ACTIVITY OF WATER-SOLUBLE ESTERS OF ACYCLOVIR [9-[(2-HYDROXYETHOXY)METHYL]GUANINE] [J].
COLLA, L ;
DECLERCQ, E ;
BUSSON, R ;
VANDERHAEGHE, H .
JOURNAL OF MEDICINAL CHEMISTRY, 1983, 26 (04) :602-604
[6]   SENSITIVITY OF HERPES-VIRUS ISOLATES FROM ACYCLOVIR CLINICAL-TRIALS [J].
COLLINS, P ;
APPLEYARD, G ;
OLIVER, NM .
AMERICAN JOURNAL OF MEDICINE, 1982, 73 (1A) :380-382
[7]   INTRAVENOUS ACYCLOVIR FOR THE TREATMENT OF PRIMARY GENITAL HERPES [J].
COREY, L ;
FIFE, KH ;
BENEDETTI, JK ;
WINTER, CA ;
FAHNLANDER, A ;
CONNOR, JD ;
HINTZ, MA ;
HOLMES, KK .
ANNALS OF INTERNAL MEDICINE, 1983, 98 (06) :914-921
[8]   A TRIAL OF TOPICAL ACYCLOVIR IN GENITAL HERPES-SIMPLEX VIRUS-INFECTIONS [J].
COREY, L ;
NAHMIAS, AJ ;
GUINAN, ME ;
BENEDETTI, JK ;
CRITCHLOW, CW ;
HOLMES, KK .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 306 (22) :1313-1319
[9]   PHARMACOKINETICS OF ACYCLOVIR AFTER INTRAVENOUS AND ORAL-ADMINISTRATION [J].
DEMIRANDA, P ;
BLUM, MR .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1983, 12 :29-37
[10]  
DEMIRANDA P, 1981, J PHARMACOL EXP THER, V219, P309